Table 3 Summary of NRF2 associated miRNAs in cancer.

From: Crosstalk between noncoding RNAs and ferroptosis: new dawn for overcoming cancer progression

Name

Associated cancer type

Target

Influence to NRF2

Model of evidence

Reference

miR-141

Hepatocellular carcinoma, ovarian cancer

KEAP1

Up

Cell culture

88,91,92,93

miR-23a

Leukemic

KEAP1

Up

Cell culture, animal models

94

miR-432

Esophageal cancer

KEAP1

Up

Cell culture

92,95

miR-7

Neuroblastoma cells

KEAP1

Up

Cell culture

92

miR-200a

Breast cancer, esophageal cancer, hepatocellular carcinoma, and pancreatic adenocarcinomas

KEAP1,

Up

Cell culture, animal models

81,92,96,97,215,216

miR-155

Lung cancer

NRF2

Up

Cell culture

217

miR-101

Hepatocellular carcinoma, prostate cancer

NRF2, SOD1

Up/Down

Cell culture, animal models

88,105,218

miR-1

Lung cancer, prostate cancer

NRF2, SOD1

Up/Inhibited by NRF2

Cell culture, animal models

105,107

miR-206

Lung cancer, prostate cancer

NRF2, SOD1

Up/Inhibited by NRF2

Cell culture, animal models

105,106,107

miR-148b

Endometrial cancer

ERMP1

Down

Cell culture

219

miR-129

Esophageal cancer

NRF2

Down

Cell culture, animal models

80

miR-129-5a

Esophageal cancer

NRF2

Down

Cell culture, animal models

80,81

miR-129-5p

Esophageal cancer

NRF2

Down

Cell culture, animal models

80

miR-142

Esophageal cancer

NRF2

Down

Cell culture

82

miR-144

Hepatocellular carcinoma, leukemia, hepatocellular carcinoma, neuroblastoma

NRF2

Down

Cell culture

88,89

miR-144-3p

Melanoma, lung cancer, and acute myeloid leukemia

NRF2

Down

Cell culture

86,87,220,221

miR-153

Neuroblastoma, breast cancer, and oral squamous cell carcinoma

NRF2

Down

Cell culture

82,90

miR-200c

Lung cancer

NRF2

Down

Cell culture, animal models

222

miR-212-3p

Melanoma

NRF2

Down

Cell culture

86

miR-23b-3p

Melanoma

NRF2

Down

Cell culture

86

miR-27

Neuroblastoma

NRF2

Down

Cell culture, animal models

223

miR-28

Breast cancer, esophageal cancer

NRF2

Down

Cell culture

81,224

miR-340

Hepatocellular carcinoma, esophageal cancer

NRF2

Down

Cell culture

85,88,92

miR-34a

Breast cancer, colon cancer, ovarian cancer, and lung cancer

NRF2

Down

Cell culture

225,226

miR-450

Esophageal cancer

NRF2

Down

Cell culture

83

miR-450a

Esophageal cancer

NRF2

Down

Cell culture, animal models

80,81

miR-495

Nonsmall-cell lung cancer

NRF2

Down

Cell culture

227

miR-507

Esophageal cancer

NRF2

Down

Cell culture, animal models

80,81,84

miR-634

Esophageal cancer

NRF2

Down

Cell culture, animal models

80,81,85

miR-93

Pancreatic adenocarcinomas, breast cancer

NRF2

Down

Cell culture, animal models

97,221

miR-93-5p

Melanoma

NRF2

Down

Clinical samples

86

miR-125b

Acute myelocytic leukemia, oral squamous cell carcinoma, and renal cancer

NRF2

Down/Induced by NRF2

Cell culture, animal models

98,99,228

miR-181c

Colorectal cancer

–

Inhibited by NRF2

Cell culture, animal models

102

miR-378

Mucoepidermoid carcinoma

–

Inhibited by NRF2

Cell culture, animal models

103

miR-122

Hepatocellular carcinoma

–

Inhibited by NRF2

Cell culture

104

miR-17-5p

Multiple myeloma

–

Inhibited by NRF2

Cell culture, animal models

66

miR-29B1

Acute myelocytic leukemia

–

Induced by NRF2

Cell culture

98

miR-129-3p

Hepatocellular carcinoma

–

Induced by NRF2

Cell culture, animal models

100

miR-380-3p

Neuroblastoma

–

Induced by NRF2

Cell culture, animal models

101